LinkedIn

 آمار

تعداد نشریات21
تعداد شماره‌ها1,306
تعداد مقالات11,943
تعداد مشاهده مقاله83,522,119
تعداد دریافت فایل اصل مقاله122,214,545
Taghvaeikeshtkar, Zahra, Riahi, Leila, Nazarimanesh, Leila, Hajinabi, Kamran. (1405). A Comparative Study of Non-Communicable Diseases Management During Pandemics in Iran and Selected Countries. سامانه مدیریت نشریات علمی, 14(3), 188-203. doi: 10.30476/jhsss.2025.108172.2111
Zahra Taghvaeikeshtkar; Leila Riahi; Leila Nazarimanesh; Kamran Hajinabi. "A Comparative Study of Non-Communicable Diseases Management During Pandemics in Iran and Selected Countries". سامانه مدیریت نشریات علمی, 14, 3, 1405, 188-203. doi: 10.30476/jhsss.2025.108172.2111
Taghvaeikeshtkar, Zahra, Riahi, Leila, Nazarimanesh, Leila, Hajinabi, Kamran. (1405). 'A Comparative Study of Non-Communicable Diseases Management During Pandemics in Iran and Selected Countries', سامانه مدیریت نشریات علمی, 14(3), pp. 188-203. doi: 10.30476/jhsss.2025.108172.2111
Taghvaeikeshtkar, Zahra, Riahi, Leila, Nazarimanesh, Leila, Hajinabi, Kamran. A Comparative Study of Non-Communicable Diseases Management During Pandemics in Iran and Selected Countries. سامانه مدیریت نشریات علمی, 1405; 14(3): 188-203. doi: 10.30476/jhsss.2025.108172.2111

A Comparative Study of Non-Communicable Diseases Management During Pandemics in Iran and Selected Countries

Journal of Health Sciences & Surveillance System
دوره 14، شماره 3، مهر 2026، صفحه 188-203    اصل مقاله (776.38 K)
نوع مقاله: Review Articles
شناسه دیجیتال (DOI): 10.30476/jhsss.2025.108172.2111
نویسندگان
Zahra Taghvaeikeshtkar1؛ Leila Riahi* 1؛ Leila Nazarimanesh2؛ Kamran Hajinabi2
1Department of Health Services Management, SR.C., Islamic Azad University, Tehran, Iran
2Department of Health Services Management, SR.C, Islamic Azad University, Tehran, Iran.
چکیده
Introduction: Maintaining continuity of care for patients with chronic non-communicable diseases (NCDs) is imperative during pandemics. This study evaluates NCD management strategies by conducting a comparative analysis between Iran and seven other nations.
Methods: This comparative qualitative study, conducted in 2023, employed sampling to examine Iran against Germany, Canada, the United States, Singapore, Australia, the United Kingdom, and Turkey. The study focused on five core components: health workforce, health information systems, medical products, health financing, and leadership and governance. Data were extracted from reputable scientific databases and analyzed using the four stage Adaptive Education Model (description, interpretation, juxtaposition, and comparison).
Results: The comparative analysis identified eleven key components influencing NCD management during pandemics. These included the presence of a comprehensive national strategy, effective inter sectoral collaboration and coordination across governmental levels, access to sufficient financial resources and appropriate allocation, the efficiency and effectiveness of the financial system, optimal workforce density and distribution, community resilience and welfare, availability and quality of essential products, medications and technologies, integration of COVID-19 related data, data quality and accuracy, and the utilization of telemedicine.
Conclusion: The findings of this study, by pinpointing critical sub-components of NCD management during pandemics, can assist policymakers and health system managers in improving planning and enhancing NCD management in crises. By focusing on the gaps and international lessons learned, this research offers an opportunity to strengthen Iran’s healthcare system and reduce inequalities in access to health services.

تازه های تحقیق

Zahra Taghvaeikeshtkar (Google Scholar)

Leila Riahi (Google Scholar)

کلیدواژه‌ها
Noncommunicable Diseases؛ Pandemics؛ Health Services Administration؛ Comparative Study؛ International Comparison؛ Iran
مراجع
  1. Herrick C, Reubi D. The future of the global noncommunicable disease agenda after COVID-19. Health Place. 2021;71:102672. PubMed PMID: 34543839; PubMed Central PMCID: PMC8440163.
  2. Jailobaeva K, Falconer J, Loffreda G, Arakelyan S, Witter S, Ager A. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries. Glob Health. 2021;17:1-15. PubMed PMID: 34187499; PubMed Central PMCID: PMC8240078.
  3. Kendzerska T, Zhu DT, Gershon AS, Edwards JD, Peixoto C, Robillard R, et al. The effects of the health system response to the COVID-19 pandemic on chronic disease management: a narrative review. Risk Manag Healthc Policy. 2021;14:575-584. DOI:10.2147/RMHP.S293471. PubMed PMID: 33623448; PubMed Central PMCID: PMC7894869.
  4. Reynolds R, Dennis S, Hasan I, Slewa J, Chen W, Tian D, et al. A systematic review of chronic disease management interventions in primary care. BMC Fam Pract. 2018;19:11. DOI: 10.1186/s12875-017-0692-3. PubMed PMID: 29316889; PubMed Central PMCID: PMC5759778.
  5. Frumkin H, Haines A. Global environmental change and noncommunicable disease risks. Annu Rev Public Health. 2019;40:261-282.
  6. World Health Organization. Non-communicable disease prevention and control: a guidance note for investment cases. Geneva: World Health Organization; 2019. DOI: 7748/ns2012.10.27.8.30.p9730.
  7. Bardhan I, Chen H, Karahanna E. Connecting systems, data, and people: a multidisciplinary research roadmap for chronic disease management. MIS Q. 2020;44(1):185-200.
  8. Hacker KA, Briss PA, Richardson L, Wright J, Petersen R. COVID-19 and chronic disease: the impact now and in the future. Prev Chronic Dis. 2021;18.
  9. Nugent R, Bertram MY, Jan S, Niessen LW, Sassi F, Jamison DT. Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals. Lancet. 2018;391(10134):2029-2035.
  10. World Health Organization. The impact of the COVID-19 pandemic on noncommunicable disease resources and services: results of a rapid assessment. Geneva: World Health Organization; 2020. DOI: 7748/ns2012.10.27.8.30.p9730.
  11. Malta DC, Duncan BB, Barros MBDA, Katikireddi SV, Souza FM, Silva AGD, et al. Fiscal austerity measures hamper noncommunicable disease control goals in Brazil. Cien Saude Colet. 2018;23:3115-3122. PubMed PMID: 30281725.
  12. Kretchy IA, Asiedu-Danso M, Kretchy JP. Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from low- and middle-income countries. Res Social Adm Pharm. 2021;17(1):2023-2026. PubMed PMID: 32414640; PubMed Central PMCID: PMC7227646.
  13. Riera R, Bagattini ÂM, Pacheco RL, Pachito DV, Roitberg F, Ilbawi A. Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review. JCO Glob Oncol. 2021;7:311-323. PubMed PMID: 33786081; PubMed Central PMCID: PMC8004854.
  14. Ahmed SAS, Ajisola M, Azeem K, Bakibinga P, Chen YF, Choudhury NN, et al. Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements. BMJ Glob Health. 2020;5(8):e003042. PubMed PMID: 32816972; PubMed Central PMCID: PMC7436504.
  15. Manyazewal T. Using the World Health Organization health system building blocks through survey of healthcare professionals to determine the performance of public healthcare facilities. Arch Public Health. 2017;75:50. DOI: 1186/s13690-017-0221-9. PubMed PMID: 28830542; PubMed Central PMCID: PMC5568324.
  16. World Health Organization. Key components of a well functioning health system. Geneva: World Health Organization; 2010. DOI: 7748/ns2012.10.27.8.30.p9730.
  17. Aromataris E, Munn Z. JBI manual for evidence synthesis. Adelaide: JBI; 2020.
  18. Adick C. Bereday and Hilker: origins of the ‘four steps of comparison’ model. Comp Educ. 2018;54(1):35-48. DOI: 4324/9780429287381-3.
  19. Gassner L, Zechmeister-Koss I, Reinsperger I. National strategies for preventing and managing non-communicable diseases in selected countries. Front Public Health. 2022;10:838051. PubMed PMID: 35173786; PubMed Central PMCID: PMC8841194.
  20. Brüchert T, Quentin P, Baumgart S, Bolte G. Barriers, facilitating factors, and intersectoral collaboration for promoting active mobility for healthy aging—a qualitative study within local government in Germany. Int J Environ Res Public Health. 2021;18(7):3807. PubMed PMID: 33917034; PubMed Central PMCID: PMC8037722.
  21. Bauer UE, Briss PA, Goodman RA, Bowman BA. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet. 2014;384:45-52. PubMed PMID: 24996500; PubMed Central PMCID: PMC4156785.
  22. Tan KB, Lee CE. Integration of primary care with hospital services for sustainable universal health coverage in Singapore. Health Syst Reform. 2019;5(1):18-23. DOI: 1080/23288604.2018.1543830. PubMed PMID: 30672377; PubMed Central PMCID: PMC6618173.
  23. Pinter KA, Zhang H, Liu C, Tran BX, Chokshi M, Lucerno-Prisno DE, et al. Elements and performance indicators of integrated healthcare programmes on chronic diseases in six countries in the Asia-Pacific region: a scoping review. Int J Integr Care. 2021;21. PubMed PMID: 34401492; PubMed Central PMCID: PMC8366504.
  24. Kayikcioğlu M, Oto A. Control and management of cardiovascular disease in Turkey. Circulation. 2020;141(1):7-9. PubMed PMID: 31826706.
  25. Akrami F, Riazi-Isfahani S, Mahdavi Hezaveh A, Ghanbari Motlagh A, Najmi M, Afkar M, et al. Iran's status of NCDs prevention and management services during COVID-19 pandemic at PHC level. 2021.
  26. Haldane V, De Foo C, Abdalla SM, Jung AS, Tan M, Wu S, et al. Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries. Nat Med. 2021;27(6):964-980. PubMed PMID: 34002090; PubMed Central PMCID: PMC8149194.
  27. Simões J, Magalhães JPM, Biscaia A, da Luz Pereira A, Augusto GF, Fronteira I. Organisation of the state, model of health system and COVID-19 health outcomes in six European countries, during the first months of the COVID-19 epidemic in 2020. Int J Health Plann Manage. 2021;36(5):1874-1886. PubMed PMID: 34151417; PubMed Central PMCID: PMC8218267.
  28. Schneider H, Okeyo I, du Toit A, Engelbrecht B, London L, Pegram E, et al. Intersectoral collaboration before and during the COVID-19 pandemic in the Western Cape: implications for future whole-of-society approaches to health and wellbeing. S Afr Health Rev. 2022.
  29. Rabeneck L, McCabe CA, Dobrow MJ, Ruco A, Andrew MK, Wong S, et al. Strengthening health care in Canada post-COVID-19 pandemic. FACETS. 2023;8:1-10. PubMed Central PMCID: PMC10118082.
  30. Mandel-Ricci J, Belfi K. Regional health system coordination via a hospital association: a successful model for managing Downstate New York's second COVID-19 wave. Health Secur. 2022;20(6):504-509. PubMed PMID: 36185027; PubMed Central PMCID: PMC9757111.
  31. Rigby RC, Ferdinand AO, Kum HC, Schmit C. Data sharing in a decentralized public health system: lessons from COVID-19 syndromic surveillance. JMIR Public Health Surveill. 2024;10:e52587. PubMed PMID: 38788667; PubMed Central PMCID: PMC11119213.
  32. Warde PR, Patel S, Ferreira T, Gershengorn H, Bhatia MC, Parekh D, et al. Linking prediction models to government ordinances to support hospital operations during the COVID-19 pandemic. BMJ Health Care Inform. 2021;28(1). PubMed PMID: 34006421; PubMed Central PMCID: PMC8132266.
  33. Chua AQ, Tan MMJ, Verma M, Han EKL, Hsu LY, Cook AR, et al. Health system resilience in managing the COVID-19 pandemic: lessons from Singapore. BMJ Glob Health. 2020;5(9):e003317. PubMed PMID: 32847936; PubMed Central PMCID: PMC7449195.
  34. Andrade AQ, Calabretto JP, Pratt NL, Kalisch-Ellett LM, Le Blanc VT, Roughead EE. Precision public-health intervention for care coordination: a real-world study. Br J Gen Pract. 2023;73(728):e220-e230. PubMed PMID: 36868846; PubMed Central PMCID: PMC10089706.
  35. Clay-Williams R, Rapport F, Braithwaite J. The Australian health system response to COVID-19 from a resilient health care perspective: what have we learned? Public Health Res Pract. 2020;30(4). PubMed PMID: 33300504; PubMed Central PMCID: PMC7726193.
  36. Larkins SL, Allard NL, Burgess CP. Management of COVID-19 in the community and the role of primary care: how the pandemic has shone light on a fragmented health system. Med J Aust. 2022;217(Suppl 9):S3-S6. PubMed PMID: 36066520.
  37. Vrijhoef HJM. Changing perspectives: from care coordination to health coordination. Int J Care Coord. 2021;24:89-90. DOI: 1177/20534345211068674.
  38. Afkar M, Rezanejad Asl P, Mahdavi Hezaveh A, Akrami F, Riazi-Isfahani S, Peykari N, et al. The effect of the COVID-19 pandemic on non-communicable disease prevention and management services in the primary health care system of Iran. Med J Islam Repub Iran. 2022;36:174. PubMed PMID: 36514690; PubMed Central PMCID: PMC9740908.
  39. Akrami F, Riazi-Isfahani S, Mahdavi Hezaveh A, Ghanbari Motlagh A, Najmi M, Afkar M, et al. Primary health care model for non-communicable diseases management during COVID-19 pandemic in the Islamic Republic of Iran. Med J Islam Repub Iran. 2022;36:167. PubMed PMID: 36466145; PubMed Central PMCID: PMC9711607.
  40. Yari A, Yousefi Khoshsabegheh H, Zarezadeh Y, Amraei M, Soufi Boubakran M, Motlagh ME. Iranian primary healthcare system's response to the COVID-19 pandemic using the healthcare incident command system. PLoS One. 2023;18(8):e0290273. PubMed PMID: 37561724; PubMed Central PMCID: PMC10413402.
  41. Schmidt AE, Winkelmann J, Merkur S. Social health insurance country responses to the COVID-19 pandemic. Eur J Public Health. 2021;31(Suppl). PubMed PMID: 34156470.
  42. Bi YN, Liu YA. The health insurance fund participates in controlling the epidemic: insights from German experience in dealing with the COVID-19 pandemic. Risk Manag Healthc Policy. 2023;16:2391-2404. DOI: 2147/rmhp.s427717. PubMed PMID: 38027056; PubMed Central PMCID: PMC10678852.
  43. Zeitouny S, Cheung DC, Bremner KE, Pataky RE, Pequeno P, Matelski J, et al. The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: an interrupted time series analysis. PLoS One. 2023;18(9):e0290646. PubMed PMID: 37708605; PubMed Central PMCID: PMC10500913.
  44. Federal updates: COVID-19 financial and economic support. Ottawa: Chartered Professional Accountants of Canada; 2021. Available from: https://www.cpacanada.ca/public-interest/public-policy-government-relations/federal-updates-covid19-financial-economic-support.
  45. Gidwani R, Damberg CL. Changes in US hospital financial performance during the COVID-19 public health emergency. JAMA Health Forum. 2023;4(7):e231928. PubMed PMID: 37490328; PubMed Central PMCID: PMC10365162.
  46. Geyman J. COVID-19 has revealed America's broken health care system: what can we learn? Int J Health Serv. 2021;51(2):188-194. DOI: 1177/0020731420985640. PubMed PMID: 33485254; PubMed Central PMCID: PMC7822607.
  47. Lim JFY. Sustainable health care financing: the Singapore experience. Glob Policy. 2017;8:103-109. DOI: 1111/1758-5899.12247.
  48. Storen R. COVID-19: impacts on health and the Australian health system. Canberra: Parliament of Australia; 2022.
  49. Australian Institute of Health and Welfare. Health system spending on the response to COVID-19 in Australia 2019-20 to 2021-22: spending by area. Canberra: AIHW; 2023.
  50. Weston T. The NHS at 75: the past and future of its funding model. London: UK Parliament; 2023.
  51. Office for National Statistics. Healthcare expenditure, UK Health Accounts: 2021. London: Office for National Statistics; 2021. DOI: 1038/d41586-022-04568-6.
  52. Khan Z. The emerging challenges and strengths of the National Health Services: a physician perspective. Cureus. 2023;15(5):e38617. DOI: 7759/cureus.38617. PubMed PMID: 37251465; PubMed Central PMCID: PMC10230464.
  53. Oksuz E, Malhan S, Gonen MS, Kutlubay Z, Keskindemirci Y, Tabak F. COVID-19 healthcare cost and length of hospital stay in Turkey: retrospective analysis from the first peak of the pandemic. Health Econ Rev. 2021;11(1):39. PubMed PMID: 34471986; PubMed Central PMCID: PMC8409354.
  54. Şener O, Ayar B, Ogras S. OP40 An initiative to identify the long-term effects of COVID-19: Turkish Ministry of Health (MoH) COVID-19 follow-up centers. Int J Technol Assess Health Care. 2023;39(Suppl):S11-S.
  55. Mohammadpour M, Delavari S, Kavosi Z, Peyravi M, Izadi R, Bastani P. The necessity revealed by COVID-19 pandemic: paradigm shift of Iran's healthcare system. Front Public Health. 2023;11:1041123. PubMed PMID: 36761138; PubMed Central PMCID: PMC9902771.
  56. Behzadifar M, Ghanbari MK, Bakhtiari A, Behzadifar M, Bragazzi NL. Ensuring adequate health financing to prevent and control COVID-19 in Iran. Int J Equity Health. 2020;19:1-4. PubMed PMID: 33083325; PubMed Central PMCID: PMC7577306.
  57. Jabbari A, Salahi S, Hadian M, Khakdel Z, Hosseini E, Sheikhbardsiri H. Exploring the challenges of Iranian government hospitals related to COVID-19 pandemic management: a qualitative content analysis research from the nurses' perspective. BMC Nurs. 2022;21(1):226. PubMed PMID: 35970915; PubMed Central PMCID: PMC9377940.
  58. Jabbari A, Zakeri A, Saghafi F, Hadian M. Iranian health financing system challenges to promote health outcomes: qualitative study. J Educ Health Promot. 2023;12:149. PubMed PMID: 37207148; PubMed Central PMCID: PMC10195554.
  59. Wieler LH, Antao EM, Hanefeld J. Reflections from the COVID-19 pandemic in Germany: lessons for global health. BMJ Glob Health. 2023;8(9). PubMed PMID: 37741609; PubMed Central PMCID: PMC10511895.
  60. Sudeck G, Geidl W, Abu-Omar K, Finger JD, Krauß I, Pfeifer K. Do adults with non-communicable diseases meet the German physical activity recommendations? A cross-sectional analysis of the GEDA 2014/2015 survey. Ger J Exerc Sport Res. 2021;51(2):183-193. PubMed PMID: 33832874.
  61. McMahon M, Nadigel J, Thompson E, Glazier RH. Informing Canada's health system response to COVID-19: priorities for health services and policy research. Healthc Policy. 2020;16(1):112-124. PubMed PMID: 32624027; PubMed Central PMCID: PMC7345293.
  62. De Foo C, Verma M, Tan SY, Haldane V, Reyes KA, Garcia F, et al. Health financing policies during the COVID-19 pandemic and implications for universal health care: a case study of 15 countries. Lancet Glob Health. 2023;11(12):e1964-e1977. PubMed PMID: 38092058; PubMed Central PMCID: PMC10718418.
  63. Tan V, Lim J, Akksilp K, Chow WL, Ma S, Chen C. The societal cost of modifiable risk factors in Singapore. BMC Public Health. 2023;23(1):1285. PubMed PMID: 37442972; PubMed Central PMCID: PMC10338284.
  64. National COVID-19 Health and Research Advisory Committee. Strengthening Australia’s health system post COVID-19. Canberra: Australian Government; 2022.
  65. Australian Institute of Health and Welfare. Heart, stroke and vascular disease: Australian facts. Canberra: AIHW; 2023. DOI: 1016/s1031-170x(05)80019-4.
  66. Committee of Public Accounts. Department of Health and Social Care 2020–21 annual report and accounts: sixth report of session 2022–23. London: House of Commons; 2022. DOI: 1038/174537c0 .
  67. World Health Organization. COVID-19 significantly impacts health services for noncommunicable diseases. Geneva: WHO; 2020. DOI: 1093/humrep/deag053.
  68. Sülkü SN, Mortaş A, Küçük A. Measuring efficiency of public hospitals under the impact of COVID-19: the case of Türkiye. Cost Eff Resour Alloc. 2023;21(1):70. PubMed PMID: 37880620; PubMed Central PMCID: PMC10596880.
  69. Rajabi M, Rezaee M, Omranikhoo H, Khosravi A, Keshmiri S, Ghaedi H, et al. Cost of illness of COVID-19 and its consequences on health and economic system. Inquiry. 2022;59:469580221144398. PubMed PMID: 36544563; PubMed Central PMCID: PMC9768763.
  70. Stroth LC, Jahns F, Bode B, Stender M, Schmidt M, Baschnegger H, et al. Workforce strategies during the first wave of the COVID-19 pandemic: a retrospective online survey at intensive care units in Germany. BMC Health Serv Res. 2024;24(1):407. PubMed PMID: 38531976; PubMed Central PMCID: PMC10971844.
  71. Köppen J, Hartl K, Maier CB. Health workforce response to COVID-19: what pandemic preparedness planning and action at the federal and state levels in Germany Int J Health Plann Manage. 2021;36(S1):71-91. PubMed PMID: 33400366; PubMed Central PMCID: PMC7785773.
  72. Health Canada. Health Canada announces Coalition for Action for Health Workers. Ottawa: Government of Canada; 2022.
  73. Allin S, Campbell S, Jamieson M, Miller F, Roerig M, Sproule J. Sustainability and resilience in the Canadian health system. Toronto: University of Toronto; 2022.
  74. Wilensky GR. The COVID-19 pandemic and the US health care workforce. JAMA Health Forum. 2022;3(1):e220001. DOI: 1001/jamahealthforum.2022.0001. PubMed PMID: 35040741.
  75. Office of the Assistant Secretary for Planning and Evaluation. Impact of the COVID-19 pandemic on the hospital and outpatient clinician workforce. Washington, DC: ASPE; 2022.
  76. World Health Organization. Health workforce: WHO global health observatory. Geneva: WHO; 2024. DOI: 1093/humrep/deag053.
  77. Poh LW, Teo I, Tewani K, Tan HK, Yoon S, Sung SC. Understanding the needs of health care workers in Singapore during the COVID-19 outbreak: a qualitative analysis. Am J Infect Control. 2022;50(10):1133-1139. PubMed PMID: 35382727; PubMed Central PMCID: PMC8990366.
  78. Gillen P, Neill RD, Manthorpe J, Mallett J, Schroder H, Nicholl P, et al. Decreasing wellbeing and increasing use of negative coping strategies: the effect of the COVID-19 pandemic on the health and social care workforce. Epidemiologia (Basel). 2022;3(1):26-39. PubMed PMID: 35024345; PubMed Central PMCID: PMC8756308.
  79. Karaman I, Ildir S, Ozkaya S. A glance into healthcare delivery during COVID-19 pandemic: a survey among Turkish medical doctors. Front Med (Lausanne). 2022;9:890417. PubMed PMID: 35496187; PubMed Central PMCID: PMC9054694.
  80. Özsoy Ö. Benchmarking health infrastructure in Türkiye and other OECD countries: health workforce, medical technology and R&D activities in health. Eur J Res Dev. 2022;2(4):273-298. DOI: 56038/ejrnd.v2i4.200.
  81. Shafaghat T, Rahimi Zarchi MK, Mousavi SM, Askari R, Ranjbar M, Ebadi F. Iranian health system response to the COVID-19 pandemic. Int J Prev Med. 2023;14:52. PubMed PMID: 37273875; PubMed Central PMCID: PMC10234430.
  82. Mahmoodpour-Azari M, Rezaei S, Badiee N, Hajizadeh A, Mohammadi A, Kazemi-Karyani A, et al. The COVID-19 pandemic and healthcare utilization in Iran: evidence from an interrupted time series analysis. Osong Public Health Res Perspect. 2023;14(3):180. PubMed PMID: 37287009; PubMed Central PMCID: PMC10249218.
  83. Dehghani Tafti A, Fatehpanah A, Salmani I, Bahrami MA, Tavangar H, Fallahzadeh H, et al. COVID-19 pandemic has disrupted the continuity of care for chronic patients: evidence from a cross-sectional retrospective study in a developing country. BMC Prim Care. 2023;24(1):137. PubMed PMID: 37322592; PubMed Central PMCID: PMC10273352.
  84. Grosser J, Greiner W. Sustainability and resilience in the German health system. Partnership for Health System Sustainability and Resilience; 2021.
  85. Schmuck J, Hiebel N, Kriegsmann-Rabe M, Schneider J, Matthias JK, Erim Y, et al. Individual stress burden and mental health in health care workers during the COVID-19 pandemic: moderating and mediating effects of resilience. Int J Environ Res Public Health. 2022;19(11). PubMed PMID: 35682493; PubMed Central PMCID: PMC9177595.
  86. Waitzberg R, Gerkens S, Dimova A, Bryndová K, Vrangbæk K, Jervelund SS, et al. Balancing financial incentives during COVID-19: a comparison of provider payment adjustments across 20 countries. Health Policy. 2022;126(5):398-407. PubMed PMID: 35091078; PubMed Central PMCID: PMC8857947.
  87. Singh J, Poon DE, Alvarez E, Anderson L, Verschoor CP, Sutton A, et al. Burnout among public health workers in Canada: a cross-sectional study. BMC Public Health. 2024;24(1):48. PubMed PMID: 38166739; PubMed Central PMCID: PMC10761457.
  88. Public Health Agency of Canada. From risk to resilience: an equity approach to COVID-19—The Chief Public Health Officer of Canada’s report on the state of public health in Canada 2020. Ottawa: Public Health Agency of Canada; 2020. DOI: 14745/ccdr.v51i05a01.
  89. Modi H, Orgera K, Grover A. Exploring barriers to mental health care in the US. Research and Action Institute; 2022.
  90. Reed AC, Murmann M, Hsu A, Turnpenny A, Van Houtven C, Laberge M, et al. Risk recognition policies for the long-term care workforce during the first year of the COVID-19 pandemic: a multi-country study. J Long Term Care. 2022.
  91. Kokubun CW, Anderson KM, Manders OC, Kalokhe AS, Sales JM. Providing trauma-informed care during a pandemic: how health care workers at Ryan White-funded clinics in the southeastern United States responded to COVID-19 and its effects on their well-being. J Int Assoc Provid AIDS Care. 2024;23:23259582241235779. PubMed PMID: 38445856; PubMed Central PMCID: PMC10916027.
  92. Kendrick K, Isaac M. Mental health impact of COVID-19: Australian perspective. Indian J Psychiatry. 2020;62(Suppl 3):S373-S376. PubMed PMID: 32810340; PubMed Central PMCID: PMC7413835.
  93. Smallwood N, Bismark M, Willis K. Burn-out in the health workforce during the COVID-19 pandemic: opportunities for workplace and leadership approaches to improve well-being. BMJ Leader. 2023;7.leader-2022-000687. PubMed PMID: 37072767; PubMed Central PMCID: PMC10118969.
  94. Figueras J, Muscat NA. Health systems resilience during COVID-19: lessons for building back better. Eur J Public Health. 2021:108.
  95. Molodynski A, McLellan A, Craig T, Bhugra D. What does COVID mean for UK mental health care? Int J Soc Psychiatry. 2021;67(7):823-825. PubMed PMID: 33840237; PubMed Central PMCID: PMC8041417.
  96. World Health Organization. Supporting Turkish mental health policy and service delivery. Geneva: WHO; 2024. DOI: 1093/humrep/deag053.
  97. Office of the Inspectorate of Turkey. Special report on Turkey's fight against COVID-19 pandemic. Ankara: Office of the Inspectorate; 2020. Report No. 36.
  98. Aliakbari F, Shabani LES, Dehghan-Abnavi S, Farahmandnia H, Sahebi A. Factors affecting burnout in Iranian health care workers during COVID-19: a systematic review. Disaster Emerg Med J. 2023;8(3):166-174.
  99. World Health Organization Regional Office for the Eastern Mediterranean. Islamic Republic of Iran focuses on innovative approaches in essential mental health services amid COVID-19 pandemic. Cairo: WHO EMRO; 2021. DOI: 26719/2012.18.4.325.
  100. Pan American Health Organization. Innovative care for chronic conditions: organizing and delivering high quality care for chronic noncommunicable diseases in the Americas. Washington, DC: PAHO; 2013. DOI: 1163/1570-6664_iyb_sim_org_38844.
  101. Ministry of Health Singapore. Our journey in 2020: a reflection. Singapore: Ministry of Health; 2020.
  102. Filip R, Gheorghita Puscaselu R, Anchidin-Norocel L, Dimian M, Savage WK. Global challenges to public health care systems during the COVID-19 pandemic: a review of pandemic measures and problems. J Pers Med. 2022;12(8). PubMed PMID: 35887738; PubMed Central PMCID: PMC9319481.
  103. International Trade Administration. Turkey - medical technologies and health IT. Washington, DC: U.S. Department of Commerce; 2024. DOI: 4135/9781071920541.n57.
  104. Pormasoumi H, Rostami D, Jamebozorgi K, Mirshekarpour H, Heshmatnia J. COVID-19 management in Iran and international sanctions. Eur J Transl Myol. 2022;32(4). PubMed PMID: 36405541; PubMed Central PMCID: PMC9664651.
  105. Amberger O, Müller A, Lemke D, Müller H, Schwappach D, Wendt P, et al. Patient safety and the COVID-19 pandemic in Germany: a repeated population-based cross-sectional survey. Int J Environ Res Public Health. 2023;20(1). PubMed PMID: 36554442; PubMed Central PMCID: PMC9782117.
  106. Health Canada. Health Canada's regulatory response to COVID-19: access to health products. Ottawa: Government of Canada; 2023.
  107. S. Food and Drug Administration. Food and Drug Administration (FDA) safety guidelines. Silver Spring (MD): FDA; 2023. DOI: 10.1016/j.fsc.2026.05.006.
  108. Foo C, Verma M, Tan SM, Haldane V, Reyes KA, Garcia F, et al. COVID-19 public health and social measures: a comprehensive picture of six Asian countries. BMJ Glob Health. 2022;7(11). PubMed PMID: 36302676; PubMed Central PMCID: PMC9606910.
  109. Tablan C. Medicines Australia's response to the Department of Prime Minister and Cabinet's COVID-19 Response Inquiry. Canberra: Medicines Australia; 2023.
  110. Abbas N, Babar ZU. Marketing authorization of COVID-19 vaccines across UK, EU, and the US: fact-checking and the implications for future research. J Pharm Policy Pract. 2021;14(1):110. DOI: 4324/9781003096221-10. PubMed PMID: 34863112; PubMed Central PMCID: PMC8637225.
  111. Kayaalp E, Isik IB. COVID-19 and healthcare infrastructure in Turkey. Med Anthropol Q. 2020;30(3).
  112. Azami SR, Hosseini SM, Alimohammadzadeh K, Jafari M, Bahadori MK. International sanctions and the procurement of medical equipment in Iran: a qualitative study. Med J Islam Repub Iran. 2021;35:180. PubMed PMID: 34812279; PubMed Central PMCID: PMC8609579.
  113. National Electronic Health Record. About National Electronic Health Record (NEHR). Singapore: Synapxe; 2024. Available from: https://www.synapxe.sg/healthtech/national-programmes/national-electronic-health-record-nehr. DOI: 2139/ssrn.5032124.
  114. Australian Institute of Health and Welfare. Health information in Australia: an evolving landscape with an integrated future. Canberra: AIHW; 2022. DOI: 1016/s1031-170x(05)80019-4.
  115. Schmitt T. Implementing electronic health records in Germany: lessons (yet to be) learned. Int J Integr Care. 2023. DOI: 5334/ijic.6578.
  116. Competition Bureau Canada. Unlocking the power of health data: digital health care market study—Part 1. Gatineau (QC): Competition Bureau Canada; 2022. Available from: https://competition-bureau.canada.ca/unlocking-power-health-data.
  117. Zayas-Cabán T, Abernethy AP, Brennan PF, Devaney S, Kerlavage AR, Ramoni R, et al. Leveraging the health information technology infrastructure to advance federal research priorities. J Am Med Inform Assoc. 2020;27(4):647-651. PubMed PMID: 32091579; PubMed Central PMCID: PMC7109905.
  118. World Bank. Building an improved primary health care system in Turkey through care integration. Washington, DC: World Bank; 2019. DOI: 1596/33098.
  119. Ezzati Farahnaz, Mosadeghrad AM, Jaafaripooyan E. Resiliency of the Iranian healthcare facilities against the COVID-19 pandemic: challenges and solutions. BMC Health Serv Res. 2023;23(1):207. PubMed PMID: 36841763; PubMed Central PMCID: PMC9959618.
  120. Sumner J, Bundele A, Chong LS, Teng GG, Kowitlawakul Y, Mukhopadhyay A. Continuing chronic care services during a pandemic: results of a mixed-method study. BMC Health Serv Res. 2022;22(1):1009. PubMed PMID: 35906646; PubMed Central PMCID: PMC9336038.
  121. Phua KH. Singapore: a primary health care case study in the context of the COVID-19 pandemic. Geneva: World Health Organization; 2023.
  122. Tan CC, Lam CS, Matchar DB, Zee YK, Wong JE. Singapore's health-care system: key features, challenges, and shifts. Lancet. 2021;398(10305):1091-1104. PubMed PMID: 34579925.
  123. Field E, Dyda A, Hewett M, Weng H, Shi J, Curtis S, et al. Development of the COVID-19 Real-Time Information System for Preparedness and Epidemic Response (CRISPER), Australia. Front Public Health. 2021;9:753493. PubMed PMID: 34749559; PubMed Central PMCID: PMC8573553.
  124. Dixon BE, Holmes JH. Managing pandemics with health informatics. Yearb Med Inform. 2021;30(1):69-74. PubMed PMID: 34191892; PubMed Central PMCID: PMC8238492.
  125. Johnston I. Australia's public health response to COVID-19: what have we done, and where to from here? Aust N Z J Public Health. 2020;44(6):440-445. DOI: 1111/1753-6405.13051. PubMed PMID: 33054376; PubMed Central PMCID: PMC7554284.
  126. Mitze T, Rode J. Early-stage spatial disease surveillance of novel SARS-CoV-2 variants of concern in Germany with crowdsourced data. Sci Rep. 2022;12(1):899. DOI: 1163/2405-8262_rgg4_sim_025028. PubMed PMID: 35046382; PubMed Central PMCID: PMC8773529.
  127. Refisch L, Lorenz F, Riedlinger T, Taubenböck H, Fischer M, Grabenhenrich L, et al. Data-driven prediction of COVID-19 cases in Germany for decision making. BMC Med Res Methodol. 2022;22(1):116. PubMed PMID: 35484518; PubMed Central PMCID: PMC9051667.
  128. LeBlanc AG, Gao YJ, McRae L, Pelletier C. At-a-glance - twenty years of diabetes surveillance using the Canadian Chronic Disease Surveillance System. Health Promot Chronic Dis Prev Can. 2019;39(11):306-309. PubMed PMID: 31766964; PubMed Central PMCID: PMC6878608.
  129. Pécout C, Pain E, Chekroun M, Champeix C, Kulak C, Prieto R, et al. Impact of the COVID-19 pandemic on patients affected by non-communicable diseases in Europe and in the USA. Int J Environ Res Public Health. 2021;18(13):6697. PubMed PMID: 34207611; PubMed Central PMCID: PMC8255737.
  130. White ER, Hébert-Dufresne L. State-level variation of initial COVID-19 dynamics in the United States. PLoS One. 2020;15(10):e0240648. PubMed PMID: 33027265; PubMed Central PMCID: PMC7536097.
  131. Öncü MA, Yıldırım S, Bostancı S, Erdoğan F. The effect of COVID-19 pandemic on health management and health services: a case of Turkey. Duzce Med J. 2021;23(Special Issue):61-70.
  132. Ilhan MN, Tüzün H, Kiliç R, Yildirim N. Nonpharmaceutical interventions in Turkey and worldwide during COVID-19 pandemic. Turk J Med Sci. 2021;51(Suppl 1):3207-3214. PubMed PMID: 33414542; PubMed Central PMCID: PMC7785750.
  133. Yousefi M, Dastan I, Alinezhad F, Ranjbar M, Hamelmann C, Ostovar A, et al. Prevention and control of non-communicable diseases in Iran: the case for investment. BMC Public Health. 2022;22(1):1248. PubMed PMID: 35790853; PubMed Central PMCID: PMC9252093.
  134. Singh T, Ngoh CL, Wong K, Khan BA. Impact of telemedicine on hospitalisation and mortality rates in community-based haemodialysis centres in Singapore during the COVID-19 pandemic. Ann Acad Med Singap. 2020;49(10):756-763. PubMed PMID: 33069214.
  135. Tan NC, Tyagi S, Lee CS, Koh EYL, Goh KLS, Gong PP, et al. Effectiveness of an algorithm-driven home telemonitoring system on the metabolic control and self-care behaviour of Asian adults with type 2 diabetes mellitus: a randomised controlled trial. J Telemed Telecare. 2023. PubMed PMID: 37022589; PubMed Central PMCID: PMC10073925.
  136. Savira F, Orellana L, Hensher M, Gao L, Sanigorski A, McNamara K, et al. Use of general practitioner telehealth services during the COVID-19 pandemic in regional Victoria, Australia: retrospective analysis. J Med Internet Res. 2023;25:e39384. PubMed PMID: 37018330; PubMed Central PMCID: PMC10067165.
  137. Reay R, Kisely SR, Looi JCL. Better Access: substantial shift to telehealth for allied mental health services during COVID-19 in Australia. Aust Health Rev. 2021;45(6):675-682. PubMed PMID: 34582395; PubMed Central PMCID: PMC8479638.
  138. Beks H, Mitchell F, Charles J, Wong Shee A, McNamara K, Versace VL. Implementation of telehealth primary health care services in a rural Aboriginal Community-Controlled Health Organisation during the COVID-19 pandemic: a mixed-methods study. Rural Remote Health. 2023;23(3):7521. PubMed PMID: 37475171; PubMed Central PMCID: PMC10361542.
  139. Dittrich F, Albrecht UV, von Jan U, Malinka C, Ansorg J, Jung J, et al. The Digital Healthcare Act: a turning point in the German digitisation strategy? Z Orthop Unfall. 2021;159(3):259-265. PubMed PMID: 34060647.
  140. Hajek A, De Bock F, Merkel C, Kretzler B, König HH. Use of and satisfaction with telemedicine services during the pandemic: findings from the COVID-19 Snapshot Monitoring in Germany (COSMO). Healthcare (Basel). 2022;10(1). PubMed PMID: 35030486; PubMed Central PMCID: PMC8757798.
  141. von der Groeben S, Czaplicki A, Hegerl U, Reich H. Telemedicine during the COVID-19 pandemic in Germany: results from three nationally representative surveys on use, attitudes and barriers among adults affected by depression. Internet Interv. 2023;32:100622. PubMed PMID: 37187036; PubMed Central PMCID: PMC10185735.
  142. Iyamu I, McKee G, Haag D, Gilbert M. Defining the role of digital public health in the evolving digital health landscape: policy and practice implications in Canada. Health Promot Chronic Dis Prev Can. 2024;44(2):66-69. PubMed PMID: 38382495; PubMed Central PMCID: PMC10883647.
  143. Chan-Nguyen S, Ritsma B, Nguyen L, Srivastava S, Shukla G, Appireddy R. Virtual care access and health equity during the COVID-19 pandemic: a qualitative study of patients with chronic diseases from Canada. Digit Health. 2022;8:20552076221074486. PubMed PMID: 35063278; PubMed Central PMCID: PMC8783936.
  144. Hsiao V, Chandereng T, Lankton RL, Huebner JA, Baltus JJ, Flood GE, et al. Disparities in telemedicine access: a cross-sectional study of a newly established infrastructure during the COVID-19 pandemic. Appl Clin Inform. 2021;12(3):445-458. PubMed PMID: 33974828; PubMed Central PMCID: PMC8120112.
  145. Gümüş R, Çetin M. Digital technology use in Turkey and the need for new eHealth literacy measurement tools. J Int Health Sci Manag. 2022;8(16):59-68. DOI: 1287/95eb1e72-a228-4554-905d-ffb747cb9d04.
  146. A comparative analysis of user insights for e-health development challenges in Turkey, Kingdom of Saudi Arabia, Egypt and United Arab Emirates. 2016. DOI: 17261/pressacademia.2016219945.
  147. Hajizadeh A, Monaghesh E. Telehealth services support community during the COVID-19 outbreak in Iran: activities of Ministry of Health and Medical Education. Inform Med Unlocked. 2021;24:100567. PubMed PMID: 33892813; PubMed Central PMCID: PMC8062843.
  148. Hosseini SM, Boushehri SA, Alimohammadzadeh K. Challenges and solutions for implementing telemedicine in Iran from health policymakers’ perspective. BMC Health Serv Res. 2024;24(1):50. PubMed PMID: 38171393; PubMed Central PMCID: PMC10764588.
  149. Ezzati F, Mosadeghrad AM, Jaafaripooyan E. Resiliency of the Iranian healthcare facilities against the COVID-19 pandemic: challenges and solutions. BMC Health Serv Res. 2023;23(1):207. PubMed PMID: 36841763; PubMed Central PMCID: PMC9959618.
  150. Gouya MM, Seif-Farahi K, Hemmati P. An overview of Iran's actions in response to the COVID-19 pandemic and in building health system resilience. Front Public Health. 2023;11:1073259. PubMed PMID: 36873777; PubMed Central PMCID: PMC9985324.
  151. Salamah S, Ramadhani R, Arfiana MR, Syamsuri I, Nugraha D, Illavi F, et al. Impact of the COVID-19 pandemic on the outcomes of Indonesian chronic disease management program. Electron J Gen Med. 2023.
  152. De Sarro C, Papadopoli R, Morgante MC, Pileggi C. A new emergency during the latest phase of the COVID-19 pandemic: access to healthcare services by patients with non-communicable diseases. Front Med (Lausanne). 2023;10:1261063. PubMed PMID: 37941448; PubMed Central PMCID: PMC10629652.
  153. Tsani S, Riza E, Tsiamagka P, Nassi M. Public financing and management for a sustainable healthcare sector: some lessons from the COVID-19 pandemic. In: COVID-19: Paving the Way for a More Sustainable World. 2021.
  154. Marchetti N, Marincioni F. Definition of indicators for multi-criteria decision analysis of COVID-19 emergency response and health system resilience in Italy. Environ Clim Technol. 2022;26:767-773.
  155. Klimek P, Ledebur K, Gyimesi M, Ostermann H, Thurner S. Forecasting the early impact of COVID-19 on physician supply in EU countries. Int J Health Policy Manag. 2022;13. PubMed PMID: 35369359; PubMed Central PMCID: PMC8978449.
  156. Fenton E, Wild CEK, Derraik JGB, Grant CC, Anderson YC. The need to nurture Aotearoa New Zealand's healthcare workforce. N Z Med J. 2023;136(1572):61-65.
  157. Ayalew M, Deribe B, Hussen S, Defar S, Gedefaw A. Quality of life among patients with chronic non-communicable diseases during COVID-19 pandemic in Southern Ethiopia: a cross-sectional analytical study. Front Psychiatry. 2022;13:855016. PubMed PMID: 35591892; PubMed Central PMCID: PMC9114359.
  158. Zhang X, Sun F, Wang Q. Health services for non-communicable diseases have been severely disrupted by COVID-19 based on an analysis of MicroBlog rescue data in Wuhan, China. Int J Health Plann Manage. 2022;37(3):1832-1837. PubMed PMID: 35191963; PubMed Central PMCID: PMC8854263.
  159. Hossain MS, Khan JR, Al Mamun SMA, Islam MT, Raheem E. Excess mortality during the COVID-19 pandemic (2020-2021) in an urban community of Bangladesh. PLOS Glob Public Health. 2023;3(7):e0002176. PubMed PMID: 37449118; PubMed Central PMCID: PMC10345567.
  160. Shishkova VN, Imamgayazova KE, Kapustina LA. Correction of psychoemotional disorders and short-term prognosis in patients with COVID-19. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(5):63-68. PubMed PMID: 35640580.
  161. Wu Y, Wen J, Wang X, Wang Q, Wang W, Wang X, et al. Chinese community home-based aging institution elders' self-management of chronic non-communicable diseases and its interrelationships with social support, e-health literacy, and self efficacy: a serial multiple mediation model. Patient Prefer Adherence. 2023;17:1311-1321. DOI: 1093/benz/9780199773787.article.b00194423. PubMed PMID: 37272444; PubMed Central PMCID: PMC10234263.
  162. Delobelle PA, Abbas M, Datay I, De Sa A, Levitt N, Schouw D, et al. Non-communicable disease care and management in two sites of the Cape Town Metro during the first wave of COVID-19: a rapid appraisal. Afr J Prim Health Care Fam Med. 2022;14(1):e1-e7. PubMed PMID: 35692471; PubMed Central PMCID: PMC9186957.
  163. Jaschke P, Keita S, Vallizadeh E, Kühne S. Satisfaction with pandemic management and compliance with public health measures: evidence from a German household survey on the COVID-19 crisis. PLoS One. 2023;18(2):e0281893. PubMed PMID: 36785762; PubMed Central PMCID: PMC9921753.
آمار
تعداد مشاهده مقاله: 36
تعداد دریافت فایل اصل مقاله: 46


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب